73 related articles for article (PubMed ID: 15212958)
1. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
Filion C; Labelle Y
Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
[TBL] [Abstract][Full Text] [Related]
2. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator.
Labelle Y; Bussières J; Courjal F; Goldring MB
Oncogene; 1999 May; 18(21):3303-8. PubMed ID: 10359536
[TBL] [Abstract][Full Text] [Related]
3. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
[TBL] [Abstract][Full Text] [Related]
4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
7. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
8. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
9. Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein.
Poulin H; Filion C; Ladanyi M; Labelle Y
Biochem Biophys Res Commun; 2006 Jul; 346(1):306-13. PubMed ID: 16756948
[TBL] [Abstract][Full Text] [Related]
10. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
Bertolotti A; Bell B; Tora L
Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
[TBL] [Abstract][Full Text] [Related]
13. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
Coles EG; Lawlor ER; Bronner-Fraser M
Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
[TBL] [Abstract][Full Text] [Related]
14. The EWS-Oct-4 fusion gene encodes a transforming gene.
Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
[TBL] [Abstract][Full Text] [Related]
15. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.
Clark J; Benjamin H; Gill S; Sidhar S; Goodwin G; Crew J; Gusterson BA; Shipley J; Cooper CS
Oncogene; 1996 Jan; 12(2):229-35. PubMed ID: 8570200
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
[TBL] [Abstract][Full Text] [Related]
17. Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.
Ramakrishnan R; Fujimura Y; Zou JP; Liu F; Lee L; Rao VN; Reddy ES
Oncogene; 2004 Sep; 23(42):7087-94. PubMed ID: 15273724
[TBL] [Abstract][Full Text] [Related]
18. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).
Panagopoulos I; Mencinger M; Dietrich CU; Bjerkehagen B; Saeter G; Mertens F; Mandahl N; Heim S
Oncogene; 1999 Dec; 18(52):7594-8. PubMed ID: 10602519
[TBL] [Abstract][Full Text] [Related]
19. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
[TBL] [Abstract][Full Text] [Related]
20. The PLAGL1 gene is down-regulated in human extraskeletal myxoid chondrosarcoma tumors.
Poulin H; Labelle Y
Cancer Lett; 2005 Sep; 227(2):185-91. PubMed ID: 16112421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
